Alnylam Pharmaceuticals, Inc. (ALNY) has 12 identified peers for comparison in the Healthcare sector. Peers include AMLX, APLS, BMRN, BPMC, DAWN, EXEL and others.
ALNY has a market capitalization of $45.01B, compared to an average peer market cap of $8.8B. ALNY is significantly larger than its average peer.
